Prime Medicine, Inc.
Income Statement
| Line Item | Jul 2026 | Jun 2026 | Apr 2026 | Mar 2026 | Feb 2026 | Dec 2025 | Oct 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | $1.2M |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — | — | — |
| Operating Expenses | ||||||||
| Research & Development | — | $33.4M | — | $34.1M | — | — | — | $44.0M |
| SG&A Expense | — | $11.0M | — | $17.4M | — | — | — | $11.2M |
| Operating Income | — | $-43.3M | — | $-50.7M | — | — | — | $-54.0M |
| Operating Margin | — | — | — | — | — | — | — | -4,406.0% |
| Interest Expense | — | — | — | — | — | — | — | — |
| Pretax Income | — | — | — | — | — | — | — | — |
| Income Tax Expense | — | — | — | — | — | — | — | — |
| Net Income | — | $-42.1M | — | $-49.1M | — | — | — | $-50.6M |
| Net Margin | — | — | — | — | — | — | — | -4,129.1% |
| EPS (Basic) | — | $-0.24 | — | $-0.28 | — | — | — | $-0.32 |
| EPS (Diluted) | — | $-0.24 | — | $-0.28 | — | — | — | $-0.32 |
| Shares Outstanding (Basic) | 181.4M | 177.2M | 180.6M | 177.1M | 180.6M | 180.5M | 180.5M | 160.5M |
| Shares Outstanding (Diluted) | 181.4M | 177.2M | 180.6M | 177.1M | 180.6M | 180.5M | 180.5M | 160.5M |
| Dividends Per Share | — | — | — | — | — | — | — | — |
Never ask a barber if you need a haircut.